DK1594526T3 - Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse - Google Patents

Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse

Info

Publication number
DK1594526T3
DK1594526T3 DK04713307T DK04713307T DK1594526T3 DK 1594526 T3 DK1594526 T3 DK 1594526T3 DK 04713307 T DK04713307 T DK 04713307T DK 04713307 T DK04713307 T DK 04713307T DK 1594526 T3 DK1594526 T3 DK 1594526T3
Authority
DK
Denmark
Prior art keywords
wound healing
hsp20
scarring
reduction
promote wound
Prior art date
Application number
DK04713307T
Other languages
English (en)
Inventor
Colleen Brophy
Alyssa Panitch
Catherine Parmiter
Elizabeth Furnish
Padmini Komalavilas
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Application granted granted Critical
Publication of DK1594526T3 publication Critical patent/DK1594526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
DK04713307T 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse DK1594526T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44895403P 2003-02-21 2003-02-21
US51221103P 2003-10-17 2003-10-17
US53030603P 2003-12-16 2003-12-16

Publications (1)

Publication Number Publication Date
DK1594526T3 true DK1594526T3 (da) 2006-11-13

Family

ID=32931323

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06014290.8T DK1808179T3 (da) 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremme af sårheling og/eller til formindskelse af ardannelse
DK04713307T DK1594526T3 (da) 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06014290.8T DK1808179T3 (da) 2003-02-21 2004-02-20 Anvendelse af HSP20 til fremme af sårheling og/eller til formindskelse af ardannelse

Country Status (9)

Country Link
US (3) US8101572B2 (da)
EP (2) EP1808179B1 (da)
AT (2) ATE332703T1 (da)
AU (1) AU2004216241B2 (da)
DE (2) DE602004001509T2 (da)
DK (2) DK1808179T3 (da)
ES (2) ES2268631T3 (da)
PT (1) PT1808179E (da)
WO (1) WO2004075914A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE332703T1 (de) 2003-02-21 2006-08-15 Univ Arizona Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung
JP2007508823A (ja) 2003-10-17 2007-04-12 アリゾナ ボード オブ リージェンツ 新規な熱ショックタンパク質２０関連ポリペプチドおよびその使用
JP5048772B2 (ja) * 2006-07-12 2012-10-17 ジ アリゾナ ボード オブ レジェンツ，ア ボディ コーポレイト アクティング フォア アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティ 線維性疾患及びケロイドを治療及び抑制する方法
DK2617431T3 (da) 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptidinhibitorer af HSP27-kinase og anvendelser derfor
DK2185698T3 (da) 2007-08-07 2015-07-27 Purdue Research Foundation Kinaseinhibitorer og anvendelser deraf
KR101965255B1 (ko) 2008-12-10 2019-04-03 퍼듀 리서치 파운데이션 키나아제의 세포-침투성 펩티드-기초된 저해물질
WO2011017132A2 (en) * 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2020167894A1 (en) * 2019-02-12 2020-08-20 Vanderbilt University Polypeptides for restoring endothelial function and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280038A (en) 1992-03-13 1994-01-18 Virginia Commonwealth University Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome
US5985635A (en) 1996-11-15 1999-11-16 Incyte Pharmaceuticals, Inc. Nucleic acids encoding novel human serine/threonine protein kinases
US6475490B1 (en) 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
WO2001068124A2 (en) 2000-03-15 2001-09-20 The Brigham And Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
JP2001278894A (ja) 2000-03-29 2001-10-10 Osamu Ozawa 血液循環障害予防および／または治療用医薬用組成物並びにその有効成分であるペプチド
MXPA02012717A (es) * 2000-06-21 2003-09-22 Amgen Inc Polipeptidos estromaticos-1 del colon, epiteliales, secretados, acidos nucleicos que los codifican y sus usos.
CA2458574A1 (en) 2001-08-23 2003-03-06 Arizona Board Of Regents Reagents and methods for smooth muscle therapies
AU2003260668A1 (en) 2002-04-01 2003-10-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Biological affinity based delivery systems
AU2003269985A1 (en) 2002-08-22 2004-03-11 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University, Office Of T Methods for increasing the rate of heart muscle contraction
ATE332703T1 (de) 2003-02-21 2006-08-15 Univ Arizona Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung
JP2007508823A (ja) 2003-10-17 2007-04-12 アリゾナ ボード オブ リージェンツ 新規な熱ショックタンパク質２０関連ポリペプチドおよびその使用

Also Published As

Publication number Publication date
EP1808179A3 (en) 2007-10-24
DE602004001509T2 (de) 2007-02-15
WO2004075914A1 (en) 2004-09-10
US8101572B2 (en) 2012-01-24
ATE332703T1 (de) 2006-08-15
ES2268631T3 (es) 2007-03-16
ATE455553T1 (de) 2010-02-15
US20120238508A1 (en) 2012-09-20
EP1594526B1 (en) 2006-07-12
DE602004025300D1 (de) 2010-03-11
AU2004216241A1 (en) 2004-09-10
PT1808179E (pt) 2010-03-24
EP1594526A1 (en) 2005-11-16
US20100009903A1 (en) 2010-01-14
ES2338350T3 (es) 2010-05-06
EP1808179B1 (en) 2010-01-20
AU2004216241B2 (en) 2006-12-14
US20150072936A1 (en) 2015-03-12
US8765673B2 (en) 2014-07-01
DK1808179T3 (da) 2010-04-12
DE602004001509D1 (de) 2006-08-24
EP1808179A2 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
NO20041917L (no) Spesifikke midler som binder humant angiopoietin-2
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
NO20062148L (no) Antistoffer som binder interleukin-4-reseptor
DK1687049T3 (da) Sprøjter, sprøjtegrænseflader og sprøjtestempler til anvendelse med medicinske injektorer
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
DK1287140T3 (da) Antistofmolekyler, der har specificitet overfor human tumornekrosefaktor-alfa og anvendelse deraf
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
IS2733B (is) Afleiður af díoxan-2-alkýlkarbamötum, framleiðsluaðferð þeirra, milliefni notuð við framleiðsluna, og notkun þeirra í meðferð.
DE602004028934D1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
IS2641B (is) 3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
DE60335018D1 (de) Mittel zur verhinderung von hautalterung
DK1594526T3 (da) Anvendelse af HSP20 til fremmelse af sårheling og/eller reduktion af ardannelse
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
ITMI20030897A1 (it) Procedimento e apparecchiatura per frazionare sangue.
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
DE50311406D1 (de) Verwendung von Formkörpern
DE60336746D1 (de) Trimer-proteine zur trimer-zytokine
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
DK1670498T3 (da) DNA, der koder for p185neu, og terapeutiske anvendelser deraf
ATE506960T1 (de) Medikament und verwendung zur tumortherapie
ITRM20020308A1 (it) Apparecchiatura per trattamenti terapeutici, e relativo metodo.
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
ES1053054Y (es) Controlador personal de la afinacion de gaitas.